Literature DB >> 213040

Cytomegalovirus-induced thrombocytopenia. An unusual case report.

M A Sahud, M M Bachelor.   

Abstract

A 21-year-old man had severe thrombocytopenia resistant to corticosteroid therapy. Viral studies of cytomegalovirus were 1:1,024. Although the cytomegalovirus titer returned toward normal (1:16 titer) during a period of three months, thrombocytopenia persisted and continued to remain refractory to corticosteroid therapy. Initial bone marrow morphology, platelet size, and platelet survival and sequestration were not typical of idiopathic thrombocytopenic purpura, and it is doubtful that splenectomy would have been helpful. However, when restudied six months later, platelet size was greatly increased, platelet survival was severely shortened (half-time, 2 1/4 hours), and intense splenic trapping was evident. Splenectomy was performed and resulted in normalization of the platelet count. Cytomegalovirus-associated thrombocytopenic purpura is an unusual disease that may take an unpredictable clinical course. Careful study of the mechanism of thrombocytopenia appears worthwhile when early recovery does not occur.

Entities:  

Mesh:

Year:  1978        PMID: 213040

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

Review 1.  Cytomegalovirus-induced thrombocytopenia in an immunocompetent adult.

Authors:  M J Eisenberg; B Kaplan
Journal:  West J Med       Date:  1993-05

2.  Initial transforming event in myelodysplastic syndromes may be viral: case for cytomegalovirus.

Authors:  A Raza
Journal:  Med Oncol       Date:  1998-09       Impact factor: 3.064

3.  Detection of anti-platelet antibodies in patients with idiopathic thrombocytopenic purpura (ITP) and in patients with rubella and herpes group viral infections.

Authors:  S Kahane; A Dvilansky; L Estok; I Nathan; Z Zolotov; I Sarov
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

4.  Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines.

Authors:  Alexei Shimanovsky; Devbala Patel; Jeffrey Wasser
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-01-01       Impact factor: 2.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.